Abiopharma

🔍 Gupta Vikram (Executive)

Company: SYNAPTICS Inc (SYNA)

Report Date: 2026-08-25

Detailed Transactions and Holdings:

• Sold 2,300 shares of Common Stock at $94.06 per share (Direct)
  Date: 2026-08-25 | Code: S | equity_swap_involved: 0 | shares_owned_after: 101,168.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 1,977 shares of Common Stock at $95.0 per share (Direct)
  Date: 2026-08-25 | Code: S | equity_swap_involved: 0 | shares_owned_after: 99,191.00 | transaction_form_type: 4 | Footnotes: F1, F3

Footnotes:

• F1: The shares were sold pursuant to 10b5-1 Trading Plan dated September 12, 2025.
• F2: The reported price is a weighted average. These shares were sold in multiple transactions at prices ranging from $93.73 to $94.64, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
• F3: The reported price is a weighted average. These shares were sold in multiple transactions at prices ranging from $94.74 to $95.16, inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
• REMARKS: The reporting person is Senior Vice President & General Manager, Edge Compute & Connectivity Division, and Chief Product Officer.